Ackman And Valeant Team Up To Pursue Takeover Of Allergan – ValueWalk Premium
valeant pharmaceuticals

Ackman And Valeant Team Up To Pursue Takeover Of Allergan

Activist hedge fund manager Bill Ackman is bringing his sometimes bare-knuckle expertise at the takeover game to Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) as the highly efficient roll-up company targets Botox wrinkle treatment company Allergan, Inc. (NYSE:AGN) with a takeover offer.


Activist hedge fund with successful track record at "encouraging" boards to make the "right" decisions teams with Valeant to acquire Allergan
The

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

0